South America vs United Republic of Tanzania: Proportion of the target population who received the final dose of
South America
69.0%
in 2024
United Republic of Tanzania
94.0%
in 2024
South America rank
4th
United Republic of Tanzania rank
5th
Proportion of the target population who received the final dose of over time
- South America
- United Republic of Tanzania
How they compare
United Republic of Tanzania currently reports 94.0% against 69.0% in South America, a difference of 25.0%.
That makes United Republic of Tanzania's figure about 1.4 times South America's.
The two have swapped places 1 time across 7 shared years of data; in 2018 it was South America ahead.
South America ranks 4th and United Republic of Tanzania ranks 5th of 35 groups.
Across the 2 decades both report, South America averaged higher in 1 and United Republic of Tanzania in 1.
Head to head by decade
| Decade | South America | United Republic of Tanzania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 53.5% | 33.0% | 20.5% | South America |
| 2020s | 54.4% | 71.8% | 17.4% | United Republic of Tanzania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, South America or United Republic of Tanzania?
- United Republic of Tanzania, at 94.0% against 69.0% in South America as of 2024.
- What is the difference in proportion of the target population who received the final dose of between South America and United Republic of Tanzania?
- 25.0%, with United Republic of Tanzania ahead.
- How many years of comparable data are there for South America and United Republic of Tanzania?
- 7 years are reported by both, from 2018 to 2024.
- How do South America and United Republic of Tanzania rank globally for proportion of the target population who received the final dose of?
- South America ranks 4th and United Republic of Tanzania ranks 5th of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.